Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Periocular Corticosteroids and Photodynamic Therapy in Neovascular AMD
NCT00305630Phase 3Completed
- Sponsor
- Johns Hopkins University
- Start
- Jul 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised trial in age-related macular degeneration (AMD) comparing Triamcinolone acetonide + PDT with Observation + PDT (2 arms). Primary endpoint: Fluorescein leakage from choroidal neovascularization on fluorescein angiography at 3 months. Started Jul 2002; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00305630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00305630.